Cover Image

Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, has spread globally, affecting people's lives worldwide and hindering global development. Traditional Chinese Medicine (TCM) plays a unique role in preventing and treating COVID-19. Representative prescriptions for the COVID-19 treatment...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liyuan Li (Author), Xiaoying Wang (Author), Xiao Guo (Author), Yikun Li (Author), Qiuhang Song (Author), Aiying Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach
by: Ruhao Yang, et al.
Published: (2021)

Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application
by: Wei Ren, et al.
Published: (2021)

Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis
by: Qi Wang, et al.
Published: (2021)

Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis
by: Huifang Zhang, et al.
Published: (2024)

Protective effect and mechanism of Qingfei Paidu decoction on myocardial damage mediated by influenza viruses
by: Lijuan Du, et al.
Published: (2024)

Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity
by: Yongfeng Zhou, et al.
Published: (2021)

Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis
by: Yapeng Li, et al.
Published: (2022)

Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy
by: Yujia Li, et al.
Published: (2021)

Combining Network Pharmacology and Transcriptomics to Investigate the Mechanisms of Yujiang Paidu Decoction in the Treatment of Chronic Rhinosinusitis with Nasal Polyps
by: Li Y, et al.
Published: (2024)

Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series
by: Xingyu Zong, et al.
Published: (2022)

A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
by: Jieqin Zhuang, et al.
Published: (2021)

Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19
by: Liang Hong, et al.
Published: (2022)

Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
by: Shuaishuai Chen, et al.
Published: (2021)

The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis
by: Caiyun Hu, et al.
Published: (2022)

Efficacy and safety of Lianhua Qingwen granule combined with azithromycin for mycoplasma pneumoniae pneumonia in children: a systematic review with meta-analysis and trial sequential analysis
by: Jiawei Li, et al.
Published: (2024)

Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS
by: Shuai Fu, et al.
Published: (2021)

Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis
by: Xinxin Wang, et al.
Published: (2022)

Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection
by: Dan Gao, et al.
Published: (2020)

Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification
by: Junjie Pan, et al.
Published: (2022)

Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review
by: Jianxia Wen, et al.
Published: (2020)

Protective effects of ethyl gallate and pentagalloylglucose, the active components of Qingwen Baidu Decoction, against lipopolysaccharide-induced acute lung injury in rats
by: Zhang Q, et al.
Published: (2018)

Risk factors and antibiotic sensitivity of aerobic bacteria in Chinese children with adenoid hypertrophy
by: Lujie Zuo, et al.
Published: (2022)

Ganghuo Kanggan Decoction in Influenza: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
by: Yanni Lai, et al.
Published: (2020)

Effects of Fuzheng Paidu tablet immunization on AIDS BALB/c mice
by: Mingsan Miao, et al.
Published: (2017)

Integrated Network Pharmacology and Lipidomics to Reveal the Inhibitory Effect of Qingfei Oral Liquid on Excessive Autophagy in RSV-Induced Lung Inflammation
by: Lili Lin, et al.
Published: (2021)

Genetic and structural characterisation of 20 autosomal STR loci from the Henan Han population of Central China
by: Hongyan Wu, et al.
Published: (2022)

Qingfei Litan Decoction Against Acute Lung Injury/Acute Respiratory Distress Syndrome: The Potential Roles of Anti-Inflammatory and Anti-Oxidative Effects
by: Yirui Diao, et al.
Published: (2022)

Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis
by: Yingying Yang, et al.
Published: (2021)

Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis
by: Jinxia Yuan, et al.
Published: (2022)

miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis
by: Yingxue Wang, et al.
Published: (2021)

Wu-Tou Decoction in Rheumatoid Arthritis: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
by: Qingqing Guo, et al.
Published: (2017)

Simiao Qingwen Baidu decoction inhibits Epstein-Barr virus-induced B lymphoproliferative disease and lytic viral replication
by: Xianhui Yang, et al.
Published: (2021)

Network and Experimental Pharmacology to Decode the Action of Wendan Decoction Against Generalized Anxiety Disorder
by: Jin Q, et al.
Published: (2022)

Research on the metabolic regulation mechanism of Yangyin Qingfei decoction plus in severe pneumonia caused by Mycoplasma pneumoniae in mice
by: Tianyu Zhang, et al.
Published: (2024)

A network pharmacology study on the main active constituents and key pharmacological pathways of Shaoyao Gancao decoction on Osteoarthritis
by: Qiuyue LI, et al.
Published: (2021)

IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma
by: Zikang Xing, et al.
Published: (2024)

Qingfei Huoxue Decoction and Its Active Component Narirutin Alleviate LPS-Induced Acute Lung Injury by Regulating TLR4/NF-κB Pathway Mediated Inflammation
by: Wang Y, et al.
Published: (2024)

Network pharmacology and in vitro experimental verification to explore the mechanism of Sanhua decoction in the treatment of ischaemic stroke
by: Wei Zhang, et al.
Published: (2022)

The potential mechanism of huazhuojiedu decoction in the treatment of ulcerative colitis based on network pharmacology and experimental validation
by: Xuemei Jia, et al.
Published: (2022)

Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation
by: Liu Y, et al.
Published: (2023)